Erica Braverman, MD

Summary

My research has focused on mechanisms to enhance cellular immunotherapies for cancer. My work thus far has centered on the role of AMP-activated protein kinase (AMPK) in metabolically optimizing Chimeric antigen receptor (CAR)T cells for the in vivo environment. I currently work with Dario Vignali to continue my efforts to optimize CART protocols by studying the impact of inhibitor receptors on CART function in both adult and pediatric models of cancer. I will also continue my work with AMPK and efforts towards metabolic optimization of CARTs using models of pediatric sarcoma.